Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Associations between blood cultures after surgery for colorectal cancer and long-term oncological outcomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Closure of the fascial defect during laparoscopic umbilical hernia repair: a randomized clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prospective observational cohort study on grading the severity of postoperative complications in global surgery research

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Clinical validation of three-dimensional ultrasound for abdominal aortic aneurysm

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Carotid Intima-Media Thickness Versus Carotid Plaque Burden for Predicting Cardiovascular Risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. How vascular surgeons can learn ultrasound

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Cutdown Technique is Superior to Fascial Closure for Femoral Artery Access after Elective Endovascular Aortic Repair

    Research output: Contribution to journalJournal articleResearchpeer-review

  • H Sillesen
  • N Eldrup
  • R Hultgren
  • J Lindeman
  • K Bredahl
  • M Thompson
  • A Wanhainen
  • U Wingren
  • J Swedenborg
  • AORTA Trial Investigators
View graph of relations

BACKGROUND: Abdominal aortic aneurysm (AAA) is thought to develop as a result of inflammatory processes in the aortic wall. In particular, mast cells are believed to play a central role. The AORTA trial was undertaken to investigate whether the mast cell inhibitor, pemirolast, could retard the growth of medium-sized AAAs. In preclinical and clinical trials, pemirolast has been shown to inhibit antigen-induced allergic reactions.

METHODS: Inclusion criteria for the trial were patients with an AAA of 39-49 mm in diameter on ultrasound imaging. Among exclusion criteria were previous aortic surgery, diabetes mellitus, and severe concomitant disease with a life expectancy of less than 2 years. Included patients were treated with 10, 25 or 40 mg pemirolast, or matching placebo for 52 weeks. The primary endpoint was change in aortic diameter as measured from leading edge adventitia at the anterior wall to leading edge adventitia at the posterior wall in systole. All ultrasound scans were read in a central imaging laboratory.

RESULTS: Some 326 patients (mean age 70·8 years; 88·0 per cent men) were included in the trial. The overall mean growth rate was 2·42 mm during the 12-month study. There was no statistically significant difference in growth between patients receiving placebo and those in the three dose groups of pemirolast. Similarly, there were no differences in adverse events.

CONCLUSION: Treatment with pemirolast did not retard the growth of medium-sized AAAs.

REGISTRATION NUMBER: NCT01354184 (https://www.clinicaltrials.gov).

Original languageEnglish
JournalThe British journal of surgery
Volume102
Issue number8
Pages (from-to)894-901
Number of pages8
ISSN0007-1323
DOIs
Publication statusPublished - Jul 2015

    Research areas

  • Aged, Aged, 80 and over, Anti-Inflammatory Agents, Aortic Aneurysm, Abdominal, Double-Blind Method, Female, Humans, Male, Mast Cells, Middle Aged, Pyridines, Pyrimidinones

ID: 45697475